Abdulla A. Damluji/X
Nov 18, 2025, 08:52
Aspirin or P2Y12 Monotherapy?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?
Very nice review.”
Stay informed with Hemostasis Today.
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country
-
Dec 16, 2025, 11:03Matías J Alet on CABOS Project with The Support of WSO
-
Dec 16, 2025, 00:32New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
-
Dec 15, 2025, 23:36In a Time of Crisis: Dr. Amanda Rischbieth on Blood Donation, Solidarity, and Saving Lives